Our mission is to become a transnational pharmaceutical company through the development and introduction of a wide portfolio of branded and generic products in key markets.
GENERICS
Lupin Pharmaceuticals, Inc. entered the U.S. generic pharmaceutical market in 2003 with the ANDA approval for cefuroxime axetil.
SPECIALTY
We are very pleased to be able to bring Suprax® an important anti-infective product in pediatric practice, back to the US market.
API
We are recognized as a leading manufacturer of cephalosporin API’s, with FDA approval to manufacture complex oral and injectable cephalosporins.
LUPIN
Lupin is amongst the world's largest manufacturers of products in its chosen therapeutic areas.
Lupin Receives “Best New Manufacturer of the Year” Award from AmerisourceBergen
Lupin receives final approval for Amlodipine Tablets.
Lupin announces Final Approval of Trandolapril Tablets.
Lupin Receives US FDA Approval for Ziprasidone HCl Capsules.
Copyright © 2006. All rights reserved.
Created and Designed by
GM